ASPG and acute lymphoblastic leukemia: Indeed, GCN2 inhibitors render ALL cells to be more sensitive to L-asparaginase treatment by inhibiting ASNS induction, consequently reducing global protein synthesis and triggering apoptosis, likely through stress-activated MAP kinase pathways [50].